NeOnc Technologies Holdings Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $40K-51.8% YoYTTM through 30 Jun 2026
Net Income -$62.1MTTM through 30 Jun 2026
Free Cash Flow -$21.7MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Operating Margin | -145,637.5% |
| Net Margin | -155,404.4% |
Returns
335.4%ROE
Balance Sheet Health
Debt / Equity-0.02x
Current Ratio0.18x
Net Debt-$1.7Mnet cash position
Cash & Equivalents$2M
Quality Metrics
Altman Z-Score-74.99
Piotroski F-Score2 / 9
FCF Margin-54,155.2%
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $40K
Diluted EPS-$2.12TTMFY2025: $-3.20
Dividend
No dividend
Capital Allocation
R&D Spend$5.9M
Capex Intensity1,250.3%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.